multipl
sclerosi
ms
affect
approxim
individu
unit
state
clinic
symptomolog
rang
rel
benign
devast
sever
case
ms
render
person
unabl
write
speak
walk
ms
patient
experienc
muscl
weak
extrem
difficulti
coordin
balanc
cours
diseas
differ
among
affect
individu
exhibit
relapsingremit
diseas
progress
diseas
like
presum
autoimmun
diseas
ms
common
femal
clinic
symptom
often
first
manifest
young
adulthood
diseas
character
develop
lesion
central
nervou
system
cn
inflammatori
compon
frequent
alway
demyelin
locat
lesion
within
cn
differ
amongst
affect
individu
occur
sever
differ
locat
one
individu
epidemiolog
studi
ms
implic
environment
well
genet
factor
diseas
process
evid
accumul
infecti
agent
particularli
viral
may
involv
howev
remain
controversi
infecti
agent
involv
alon
may
suffici
initi
observ
patholog
primari
experiment
anim
model
studi
ms
experiment
autoimmun
enceph
eae
diseas
incit
aggress
immun
specif
peptid
mice
rat
model
use
extens
proven
extrem
use
eae
includ
group
diseas
model
differ
term
speci
strain
anim
use
agentpeptid
use
elicit
autoimmun
respons
protocol
use
immun
includ
type
adjuv
employ
diseas
process
influenc
variabl
therefor
care
must
taken
extrapol
result
one
eae
model
anoth
current
avail
model
base
viral
infect
found
infect
caus
demyelin
mice
howev
combin
infect
administr
mslike
patholog
cn
inflammatori
demyelin
observ
infect
mice
inflammatori
demyelin
occur
deliv
use
viral
vector
mice
inject
infect
wildtyp
wt
ocular
infect
differ
strain
mice
induc
cn
demyelin
periventricular
white
matter
brain
stem
stem
cell
sc
white
matter
optic
nerv
infect
mice
wherea
wt
recombin
virus
express
induc
demyelin
neuropathi
similar
result
obtain
upon
deliveri
mous
brain
use
osmot
minipump
inject
mice
protein
dna
synthet
peptid
prior
infect
wt
strain
mckrae
ko
notabl
singl
mutat
posit
openread
frame
complet
block
cn
demyelin
model
thu
model
cn
demyelin
offer
novel
altern
experiment
anim
model
ms
incorpor
viral
immun
compon
avail
two
independ
anim
model
could
prove
extrem
use
elucid
pathogen
mechan
underli
human
diseas
identifi
effect
therapeut
strategi
effect
use
model
depend
howev
thorough
understand
similar
differ
among
model
especi
term
paramet
like
relat
human
diseas
therefor
studi
compar
model
cn
demyelin
model
eae
use
standard
protocol
femal
mice
age
also
compar
effect
control
cn
demyelin
deliveri
differ
model
result
simultan
comparison
differ
model
cn
demyelin
provid
insight
possibl
relev
ultim
ms
sixweekold
femal
mice
administ
mog
mbp
plp
peptid
infect
recombin
viru
describ
materi
method
mice
per
group
treatment
group
refer
mog
mbp
plp
hereaft
day
pi
mice
sacrif
brain
sc
on
collect
postfix
stain
myelin
stain
lfb
repres
photomicrograph
lfbstain
brain
sc
section
shown
figur
demyelin
observ
brain
sc
mice
treatment
group
demyelin
also
observ
mice
mog
treatment
group
howev
demyelin
detect
mice
mbp
plp
treatment
group
visual
inspect
slide
suggest
sever
cn
demyelin
greater
mice
mog
treatment
group
mbp
plp
treatment
group
quantifi
extent
demyelin
count
number
measur
size
observ
demyelin
plaqu
brain
sc
on
data
shown
area
demyelin
per
total
stain
section
figur
area
brain
demyelin
significantli
greater
mice
mog
treatment
group
mice
plp
mbp
group
fig
brain
although
area
brain
demyelin
somewhat
higher
group
mog
group
differ
reach
statist
signific
fig
brain
p
mice
treat
mbp
group
show
lowest
degre
brain
demyelin
four
experiment
group
fig
brain
contrast
observ
differ
level
demyelin
brain
mice
differ
treatment
group
level
sc
demyelin
similar
group
fig
sc
area
demyelin
greater
on
mice
mog
group
on
mice
ocularli
infect
fig
demyelin
detect
on
mice
plp
mbp
group
fig
inflamm
one
site
cn
associ
initi
event
ms
result
figur
suggest
greater
demyelin
brain
on
mice
mog
treatment
group
plp
mbp
group
determin
extent
demyelin
correl
level
inflamm
stain
section
brain
sc
on
h
e
figur
estim
sever
inflamm
describ
materi
method
data
shown
inflammatori
score
per
total
stain
section
figur
inflammatori
score
section
brain
sc
mice
mog
treatment
group
similar
mice
plp
mbp
group
fig
contrast
inflammatori
score
on
mice
mog
treatment
group
significantli
higher
score
mice
plp
mbp
group
fig
inflammatori
respons
on
mog
treatment
group
correl
sever
demyelin
fig
except
howev
overal
inflammatori
respons
correl
sever
demyelin
mani
cell
type
implic
ms
anim
model
ms
investig
contribut
cell
b
cell
macrophag
dendrit
cell
dc
develop
autoimmun
cn
differ
model
assess
number
immun
cell
brain
sc
multiparamet
flow
cytometri
analysi
cell
stain
mab
describ
materi
method
three
main
popul
common
leukocyt
antigen
cell
identifi
brain
sc
base
express
fig
fig
fig
mice
treatment
group
highest
number
cell
brain
sc
compar
mice
group
fig
p
among
eae
model
mog
mice
highest
number
cell
fig
p
cell
detect
sc
control
mice
fig
number
cell
high
brain
treatment
group
includ
mocktreat
control
group
fig
p
higher
number
cell
also
found
sc
mocktreat
control
group
compar
group
number
cell
lower
treatment
group
treatment
group
fig
lower
amount
cell
sc
infect
mice
suggest
infect
suppress
cell
tissu
signific
differ
number
cell
among
group
except
number
cell
significantli
higher
sc
mice
mog
group
fig
overal
number
cell
higher
fig
compar
fig
fig
brain
treatment
group
includ
mocktreat
control
group
b
cell
infiltr
detect
brain
sc
mice
treatment
group
shown
patient
ms
exhibit
limb
weak
paralysi
earli
patholog
chang
lumbar
spinal
cord
tissu
describ
mous
ms
model
occur
presenc
absenc
overt
clinic
symptom
mice
monitor
score
daili
sign
paralysi
day
death
earlier
day
use
score
system
describ
materi
method
mean
day
onset
mean
maximum
clinic
score
incid
symptom
mortal
calcul
greater
mice
mog
treatment
group
show
sign
muscular
weak
tabl
among
mice
mog
group
first
sign
paralysi
usual
tail
hypotonia
atonia
appear
day
postmog
inject
differ
degre
hind
limb
paralysi
observ
among
mice
day
inject
final
experiment
time
point
contrast
sign
paralysi
observ
mice
mbp
tabl
plp
tabl
tabl
treatment
group
within
timefram
experi
use
treatment
relapsingremit
type
ms
rrm
therefor
explor
abil
block
reduc
cn
demyelin
differ
mous
model
mice
inject
dna
vector
dna
describ
materi
method
demyelin
brain
sc
on
measur
day
posttreat
repres
photomicrograph
lfbstain
section
shown
figur
data
summar
tabl
inject
dna
reduc
demyelin
brain
sc
mice
mog
group
complet
block
demyelin
on
figur
tabl
moreov
intramuscular
inject
dna
delay
onset
clinic
diseas
reduc
sever
clinic
symptom
elimin
mortal
group
mice
tabl
inject
dna
also
reduc
level
demyelin
brain
sc
mice
mbp
group
fig
tabl
inject
dna
result
reduct
demyelin
brain
mice
plp
group
demyelin
sc
significantli
lower
vectortr
control
fig
tabl
final
group
inject
brain
demyelin
reduc
sc
on
demyelin
block
complet
compar
group
inject
vector
dna
alon
fig
tabl
overal
effect
reduc
block
cn
demyelin
group
effect
group
follow
plp
mbp
mog
group
addit
inject
group
less
efficaci
reduc
demyelin
brain
treat
mice
sc
on
reduc
efficaci
possibl
associ
brain
immunolog
privileg
site
sc
thu
bloodbrain
barrier
may
reduc
entranc
antigen
brain
sc
may
contribut
lower
protect
demyelin
group
previous
report
ocular
infect
mice
recombin
express
inject
mice
dna
complet
block
cn
demyelin
mice
report
critic
cytokin
pathogenesi
eae
subsequ
shown
compon
involv
eaeinduc
cn
patholog
agent
block
common
chain
enter
clinic
trial
therefor
evalu
effect
cn
demyelin
variou
model
mice
inject
mog
mbp
plp
describ
figur
inject
mice
infect
ocularli
pfuey
control
mice
coinfect
plu
virus
clinic
sign
diseas
monitor
day
day
post
treatment
day
post
ocular
infect
mice
sacrif
brain
sc
on
stain
lfb
result
summar
tabl
repres
photomicrograph
lfbstain
section
shown
figur
expect
infect
result
inhibit
cn
demyelin
model
fig
tabl
infect
result
inhibit
cn
demyelin
mog
fig
tabl
mbp
fig
tabl
plp
fig
tabl
model
inde
mark
contrast
protect
effect
block
cn
demyelin
model
infect
viru
exacerb
level
demyelin
sever
paralysi
increas
mortal
mog
model
tabl
howev
infect
viru
increas
sever
demyelin
mbp
tabl
plp
tabl
model
thu
result
suggest
protect
model
promot
demyelin
exacerb
clinic
symptom
mog
model
previous
report
recombin
express
protect
rhesu
monkey
mice
autoimmun
encephalomyel
thu
determin
moginduc
cn
demyelin
block
mice
inject
mog
ocularli
infect
describ
materi
method
day
posttreat
mice
sacrif
brain
sc
on
collect
postfix
stain
lfb
lfb
data
clinic
sign
diseas
summar
tabl
result
indic
demyelin
paralysi
reduc
mice
infect
tabl
result
similar
previou
report
show
block
cn
demyelin
avail
anim
model
help
critic
understand
pathogenesi
ms
ultim
develop
method
control
diseas
recent
describ
mix
model
ms
use
viral
immun
compon
induc
cn
demyelin
model
constitut
express
murin
recombin
caus
cn
demyelin
differ
strain
mice
eae
primari
experiment
anim
model
studi
ms
signific
variat
type
diseas
model
thu
initi
studi
answer
follow
question
similaritiesdiffer
model
eae
model
similaritiesdiffer
among
entir
group
model
model
repres
differ
type
ms
result
obtain
comprehens
compar
studi
reveal
differ
clinic
relev
paramet
model
demyelin
observ
brain
sc
four
model
demyelin
model
report
previous
also
detect
mog
model
contrast
mog
model
demyelin
observ
mbp
plp
model
inflammatori
demyelin
also
call
optic
neuriti
common
caus
visual
neurolog
dysfunct
young
adult
diagnos
ms
earli
manifest
ms
often
involv
degrad
visual
acuiti
color
vision
visual
field
deficit
result
impair
vision
even
blind
result
optic
neuriti
treatment
trial
critic
longitudin
prospect
cohort
studi
establish
close
relationship
optic
neuriti
ms
patient
monosymptomat
optic
neuriti
clinic
silent
mslike
lesion
mri
brain
longer
followup
least
monosymptomat
optic
neuriti
patient
diagnos
ms
risk
develop
ms
one
episod
optic
neuriti
base
clinic
criteria
alon
measur
visualevok
cortic
potenti
vecp
wide
use
assess
patient
suspect
ms
high
sensit
techniqu
abil
detect
even
clinic
silent
lesion
visual
pathway
report
previous
mice
ocularli
infect
show
signific
delay
term
vecp
respons
compar
mice
infect
control
virus
result
compar
studi
suggest
model
mog
model
cn
demyelin
may
better
model
aspect
ms
mbp
plp
model
use
knockout
mice
deplet
studi
transfer
studi
establish
cell
involv
demyelin
b
cell
dc
nk
cell
play
role
demyelin
similarli
present
studi
found
elev
number
cell
bcell
brain
sc
infect
mice
find
consist
publish
data
concern
histolog
analys
specimen
obtain
patient
ms
autopsi
shown
possibl
correl
presenc
cell
develop
demyelin
lesion
result
also
consist
report
demyelin
induc
mous
hepat
viru
mhv
associ
cell
eae
model
ms
cell
associ
cn
demyelin
macrophag
also
implic
cn
patholog
ms
although
may
play
indirect
role
current
studi
observ
suppress
cell
sc
group
previous
shown
infect
macrophag
alter
balanc
transcript
also
report
deplet
macrophag
induc
cn
demyelin
follow
ocular
infect
deplet
mice
wt
suppress
effect
balanc
transcript
revers
similarli
studi
show
coinfect
mice
complet
block
cn
demyelin
infect
mice
contrast
result
obtain
use
model
infect
mice
mog
treatment
group
exacerb
diseas
outcom
macrophag
main
sourc
product
block
cn
demyelin
infect
mice
probabl
due
compens
suppress
effect
format
consid
critic
cytokin
pathogenesi
eae
howev
later
studi
show
although
compon
involv
eaeinduc
cn
patholog
effect
mediat
bind
rather
bind
current
studi
contrast
suppress
macrophag
observ
mice
find
alter
number
macrophag
mog
model
thu
exacerb
diseas
mog
model
follow
infect
may
due
imbal
could
contribut
develop
autoreact
cell
previous
found
cn
demyelin
observ
mice
exacerb
coinfect
recombin
viru
even
though
mice
infect
recombin
viru
alon
develop
cn
demyelin
pleiotrop
lymphokin
synthes
primarili
activ
lymphocyt
level
report
lower
normal
sera
patient
ms
recombin
shown
diminish
demyelin
improv
clinic
cours
mice
eae
appar
influenc
develop
cell
assum
protect
role
fed
mice
retinoid
group
chemic
increas
also
improv
cours
eae
addit
shown
cn
gene
therapi
vector
express
protect
rhesu
monkey
mice
autoimmun
encephalomyel
howev
studi
recombin
express
murin
block
cn
demyelin
mog
model
similarli
report
previous
cn
demyelin
block
mice
coinfect
discrep
result
studi
previou
studi
could
due
type
antigen
strain
mice
dose
infect
firstlin
therapi
patient
ms
due
suppress
inflamm
cn
current
studi
found
inject
mice
dna
significantli
reduc
block
cn
demyelin
diseas
model
use
studi
addit
delay
clinic
sign
paralysi
sever
paralysi
mog
mice
studi
detect
paralysi
mog
mice
abl
induc
paralysi
mbp
plp
mice
even
higher
dose
peptid
use
protocol
similarli
mice
show
sign
paralysi
late
day
followup
even
though
exhibit
extens
cn
demyelin
inflamm
howev
occasion
detect
paralysi
femal
balbc
mice
infect
ocularli
viru
result
studi
summar
tabl
indic
pattern
demyelin
mog
mice
demyelin
occur
brain
sc
contrast
mbp
plp
induc
demyelin
develop
demyelin
lesion
dna
intramuscular
inject
reduc
mog
mbptreat
mice
significantli
reduc
plp
mice
mark
contrast
protect
effect
mice
infect
mice
exacerb
diseas
mogtreat
mice
effect
plp
mbptreat
mice
affect
demyelin
mogtreat
mice
mogtreat
mice
group
develop
paralysi
summari
result
suggest
mog
model
share
featur
characterist
human
ms
complementari
uniqu
attribut
provid
insight
develop
diseas
sixweekold
femal
mice
purchas
jackson
laboratori
bar
harbor
plaquepurifi
grown
rabbit
skin
rs
cell
monolay
minim
essenti
medium
mem
contain
fetal
calf
serum
fc
describ
previous
previous
describ
construct
character
briefli
complet
gene
includ
polya
site
insert
downstream
lat
promot
cotransfect
infecti
dna
calcium
phosphat
method
singl
plaqu
contain
gene
plaquepurifi
describ
therefor
transcrib
mous
driven
lat
promot
respect
chose
lat
promot
sinc
promot
express
high
level
transcript
respons
primari
infect
period
latenc
construct
character
also
call
hsv
express
murin
infram
heterodim
transcript
control
murin
earlygrowth
promot
describ
previous
contrast
ocular
infect
mice
caus
cn
demyelin
ocular
infect
carri
use
standard
protocol
use
routin
mice
infect
coinfect
ocularli
pfuey
pfuey
viru
suspend
tissu
cultur
media
administ
eye
drop
mous
myelin
basic
protein
tgildsigrffsg
mous
myelin
proteolipid
protein
sktsasigslcadarmygvl
mous
myelin
oligodendrocyt
glycoprotein
mevgwyrspfsrvvhlyrngk
synthes
brain
research
center
univers
british
columbia
describ
previous
puriti
synthes
peptid
least
determin
fast
protein
liquid
chromatographi
flpc
analys
standard
protocol
use
eae
induct
use
synthet
peptid
describ
mice
inject
subcutan
peptid
complet
freund
adjuv
cfa
total
volum
four
hour
peptid
inject
mous
receiv
ng
purifi
bordetella
pertussi
toxin
calbiochem
san
diego
ca
steril
water
intraperiton
ip
repeat
h
postmyelin
peptid
inject
mice
examin
daili
day
neurolog
clinic
sign
accord
follow
criteria
normalno
overt
sign
diseas
tail
hypotonia
tail
atonia
hind
limb
weak
limb
tail
hind
limb
weak
partial
hind
limb
paralysi
complet
hind
limb
paralysi
moribund
state
death
brain
spinal
cord
sc
mice
treat
mbp
plp
mog
mock
treat
harvest
perfus
day
posttreat
tissu
three
mice
per
treatment
group
combin
cut
small
piec
treat
mgml
collagenas
type
sigma
chemic
co
h
gentl
passag
eighteengaug
syring
first
hour
singl
cell
suspens
total
cn
cell
includ
mononuclear
cell
mnc
isol
use
percol
gradient
singlecel
suspens
brain
sc
mice
per
treatment
group
stain
mab
bd
pharmingen
san
diego
ca
analyz
use
multicolor
five
laser
facscan
instrument
becton
dickinson
brain
spinal
cord
sc
optic
nerv
on
remov
necropsi
day
post
treatment
tissu
snapfrozen
isopentaneliquid
nitrogen
bath
store
transvers
section
tissu
thick
cut
airdri
overnight
fix
aceton
min
presenc
absenc
demyelin
brain
sc
on
evalu
use
lfb
stain
formalinfix
section
describ
previous
number
plaqu
size
plaqu
shape
plaqu
multipl
field
evalu
investig
blind
treatment
group
use
serial
section
cn
tissu
amount
myelin
loss
stain
section
brain
sc
on
measur
use
nih
imag
j
softwar
analysi
system
area
demyelin
clearwhit
normal
tissu
blue
quantifi
use
random
section
brain
sc
section
on
anim
demyelin
section
confirm
monitor
adjac
section
percentag
myelin
loss
calcul
divid
lesion
size
total
area
section
inflammatori
respons
quantifi
use
random
section
brain
sc
anim
h
e
stain
protocol
consist
follow
step
slide
rewarm
rt
min
deparaffin
dehydr
xylen
min
ethanol
min
follow
ethanol
min
slide
wash
tap
water
min
distil
water
min
hematoxylin
solut
appli
min
clarifi
solut
minut
run
tap
water
min
follow
blu
solut
min
run
tap
water
min
slide
dip
eosin
wash
clear
ethanol
min
time
ethanol
min
xylen
min
coverslip
mount
microscop
analysi
inflamm
perform
follow
day
investig
blind
treatment
group
base
follow
scale
infiltr
perivascular
infiltr
perivascular
inflammatori
cuff
inflamm
cn
substanc
complet
openread
frame
orf
purchas
invivogen
san
diego
ca
plasmid
dna
purifi
use
cesium
chlorid
gradient
experi
mice
inject
intramuscularli
quadricep
use
gaug
needl
cesium
chloridepurifi
dna
total
volum
pb
neg
control
use
mocktreat
mice
similarli
inject
vector
dna
alon
mice
inject
day
rel
peptid
inject
infect
